1 false false false false false false false false false false true false false false false false false No description of principal activity 2022-07-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 10843162 2022-07-01 2023-06-30 10843162 2023-06-30 10843162 2022-06-30 10843162 2021-07-01 2022-06-30 10843162 2022-06-30 10843162 2021-06-30 10843162 bus:LeadAgentIfApplicable 2022-07-01 2023-06-30 10843162 bus:Director1 2022-07-01 2023-06-30 10843162 core:WithinOneYear 2023-06-30 10843162 core:WithinOneYear 2022-06-30 10843162 bus:Micro-entities 2022-07-01 2023-06-30 10843162 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 10843162 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 10843162 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 10843162 bus:FullAccounts 2022-07-01 2023-06-30 10843162 bus:Director1 2023-06-30
COMPANY REGISTRATION NUMBER: 10843162
CM Pharma Research Limited
Filleted Unaudited Financial Statements
30 June 2023
CM Pharma Research Limited
Financial Statements
Year ended 30 June 2023
Contents
Pages
Chartered accountant's report to the director on the preparation of the unaudited statutory financial statements
1
Statement of financial position and the notes to the financial statements
2 to 3
CM Pharma Research Limited
Chartered Accountant's Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of CM Pharma Research Limited
Year ended 30 June 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of CM Pharma Research Limited for the year ended 30 June 2023, which comprise the statement of financial position and the notes to the financial statements from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/membership/regulations-standards-and-guidance. Our work has been undertaken in accordance with ICAEW Technical Release 07/16 AAF as detailed at www.icaew.com/compilation.
BROOKS & CO. Chartered accountants
9 Cheam Road Ewell Epsom Surrey KT17 1SP
6 February 2024
CM Pharma Research Limited
Statement of Financial Position
30 June 2023
2023
2022
£
£
Fixed assets
156
281
----
----
Current assets
50,219
45,246
Prepayments and accrued income
-
48
--------
--------
50,219
45,294
Creditors: amounts falling due within one year
49,046
44,682
--------
--------
Net current assets
1,173
612
-------
----
Total assets less current liabilities
1,329
893
Accruals and deferred income
721
721
-------
----
608
172
-------
----
Capital and reserves
608
172
----
----
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2022: 1 ).
2. Director's advances, credits and guarantees
During the year, Ms C Minnette , a director of the company, made further advances to the company. The amount owed to Ms C Minnette at the year-end totalled £ 47,111 (2022: £37,856).The advances are interest free and repayable on demand.
For the year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 6 February 2024 , and are signed on behalf of the board by:
Ms C Minnette
Director
Company registration number: 10843162
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Pipers Dane, Outwood Lane, Chipstead, Surrey, CR5 3NF.